BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

881 related articles for article (PubMed ID: 26574491)

  • 1. Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.
    Liguori G; Lamas B; Richard ML; Brandi G; da Costa G; Hoffmann TW; Di Simone MP; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    J Crohns Colitis; 2016 Mar; 10(3):296-305. PubMed ID: 26574491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosa-associated microbiota dysbiosis in colitis associated cancer.
    Richard ML; Liguori G; Lamas B; Brandi G; da Costa G; Hoffmann TW; Pierluigi Di Simone M; Calabrese C; Poggioli G; Langella P; Campieri M; Sokol H
    Gut Microbes; 2018 Mar; 9(2):131-142. PubMed ID: 28914591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal microbiota dysbiosis in IBD.
    Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
    Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease.
    El Mouzan MI; Korolev KS; Al Mofarreh MA; Menon R; Winter HS; Al Sarkhy AA; Dowd SE; Al Barrag AM; Assiri AA
    World J Gastroenterol; 2018 Oct; 24(39):4510-4516. PubMed ID: 30356965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between specific mucosa-associated microbiota in Crohn's disease at the time of resection and subsequent disease recurrence: a pilot study.
    De Cruz P; Kang S; Wagner J; Buckley M; Sim WH; Prideaux L; Lockett T; McSweeney C; Morrison M; Kirkwood CD; Kamm MA
    J Gastroenterol Hepatol; 2015 Feb; 30(2):268-78. PubMed ID: 25087692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.
    Li Q; Wang C; Tang C; He Q; Li N; Li J
    J Clin Gastroenterol; 2014 Jul; 48(6):513-23. PubMed ID: 24275714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
    World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ; Kühbacher T; Musfeldt M; Rosenstiel P; Hellmig S; Rehman A; Drews O; Weichert W; Timmis KN; Schreiber S
    Scand J Gastroenterol; 2008; 43(7):831-41. PubMed ID: 18584522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Siblings of patients with Crohn's disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities.
    Hedin C; van der Gast CJ; Rogers GB; Cuthbertson L; McCartney S; Stagg AJ; Lindsay JO; Whelan K
    Gut; 2016 Jun; 65(6):944-53. PubMed ID: 25856344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation-related differences in mucosa-associated microbiota and intestinal barrier function in colonic Crohn's disease.
    Libertucci J; Dutta U; Kaur S; Jury J; Rossi L; Fontes ME; Shajib MS; Khan WI; Surette MG; Verdu EF; Armstrong D
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G420-G431. PubMed ID: 29848021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R; Davies JM; Quintero MA; Damas OM; Deshpande AR; Kerman DH; Sawyer WP; Pignac-Kobinger J; Ban Y; Fernandez I; Burgueno JF; Phillips MC; Abreu MT
    Cell Mol Gastroenterol Hepatol; 2020; 9(3):387-402. PubMed ID: 31740421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease.
    Busquets D; Mas-de-Xaxars T; López-Siles M; Martínez-Medina M; Bahí A; Sàbat M; Louvriex R; Miquel-Cusachs JO; Garcia-Gil JL; Aldeguer X
    J Crohns Colitis; 2015 Oct; 9(10):899-906. PubMed ID: 26142465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transitional and temporal changes in the mucosal and submucosal intestinal microbiota in advanced Crohn's disease of the terminal ileum.
    Chiodini RJ; Dowd SE; Barron JN; Galandiuk S; Davis B; Glassing A
    J Med Microbiol; 2018 Apr; 67(4):549-559. PubMed ID: 29458679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of faecal metagenome in Crohn's disease: Role of microRNAs as biomarkers.
    Rojas-Feria M; Romero-García T; Fernández Caballero-Rico JÁ; Pastor Ramírez H; Avilés-Recio M; Castro-Fernandez M; Chueca Porcuna N; Romero-Gόmez M; García F; Grande L; Del Campo JA
    World J Gastroenterol; 2018 Dec; 24(46):5223-5233. PubMed ID: 30581271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural robustness of the gut mucosal microbiota is associated with Crohn's disease remission after surgery.
    Mondot S; Lepage P; Seksik P; Allez M; Tréton X; Bouhnik Y; Colombel JF; Leclerc M; Pochart P; Doré J; Marteau P;
    Gut; 2016 Jun; 65(6):954-62. PubMed ID: 26628508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
    Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
    Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis.
    Lemoinne S; Kemgang A; Ben Belkacem K; Straube M; Jegou S; Corpechot C; ; Chazouillères O; Housset C; Sokol H
    Gut; 2020 Jan; 69(1):92-102. PubMed ID: 31003979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbiome in Crohn's Disease: Role in Pathogenesis and Role of Microbiome Replacement Therapies.
    Khanna S; Raffals LE
    Gastroenterol Clin North Am; 2017 Sep; 46(3):481-492. PubMed ID: 28838410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Postoperative Endoscopic Recurrence in Crohn's Disease Is Characterised by Distinct Microbiota Recolonisation.
    Machiels K; Pozuelo Del Río M; Martinez-De la Torre A; Xie Z; Pascal Andreu V; Sabino J; Santiago A; Campos D; Wolthuis A; D'Hoore A; De Hertogh G; Ferrante M; Manichanh C; Vermeire S
    J Crohns Colitis; 2020 Nov; 14(11):1535-1546. PubMed ID: 32333762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.